The evolving frontier of diabetes therapy: The renaissance of glycemology

Research output: Contribution to journalArticlepeer-review


It was previously proposed that diabetes could be a “cardiovascular disease”. This concept was based on evidence showing that controlling hypertension and dyslipidemia could be more effective than controlling hyperglycemia. At that time it was concluded that the real need to focus on reaching optimal glycemic control had lost its appeal. However, the concept of glycemic control was strictly correlated to levels of glycated hemoglobin (HbA1c), the integrated measure of mean glycemia over the previous 2–3 months, while recent evidence suggests that the concept of hyperglycemia has profoundly changed, and it is more appropriate to speak of different kinds or aspects of hyperglycemia. A modern, updated approach to glycemic control in people with diabetes, in fact, must focus not only on reaching and maintaining optimal HbA1c levels as soon as possible, but to obtain this result by reducing postprandial hyperglycemia and glycemic variability, while avoiding hypoglycemia.

Original languageEnglish
Pages (from-to)168-171
Number of pages4
JournalDiabetes Research and Clinical Practice
Publication statusPublished - Aug 1 2016


  • Cardiovascular disease
  • Glucose variability
  • Glycemology
  • HbA1c
  • Hypoglycemia
  • Postprandial hyperglycemia

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Endocrinology


Dive into the research topics of 'The evolving frontier of diabetes therapy: The renaissance of glycemology'. Together they form a unique fingerprint.

Cite this